Table 2.
Adjustedb Time dependenta HR [95% CI] | Univariate Time dependenta HR [95% CI] | Adjustedb Time dependenta HR [95% CI] | Adjustedb Time averagec HR [95% CI] | ||
---|---|---|---|---|---|
Overalld | |||||
PD | 1.0 | PD | 1.0 | 1.0 | 1.0 |
HD | 1.0 [1.0, 1.1] | HD-CVC | 1.7 [1.6, 1.7] | 1.2 [1.1, 1.2] | 1.2 [1.1 1.2] |
HD-AVF/AVG | 1.1 [1.0, 1.1] | 0.8 [0.8, 0.9] | 0.8 [0.8,0.9] | ||
Year 1 | |||||
PD | 1.0 | PD | 1.0 | 1.0 | 1.0 |
HD | 1.5 [1.4,1.7] | HD-CVC | 2.7 [2.4, 2.9] | 1.8 [1.6, 1.9] | 1.6 [1.5, 1.8] |
HD-AVF/AVG | 1.1 [1.0, 1.3] | 0.9 [0.8, 1.1] | 0.9 [0.8,1.1] | ||
Year 2 | |||||
PD | 1.0 | PD | 1.0 | 1.0 | 1.0 |
HD | 1.0 [0.9, 1.1] | HD-CVC | 1.5 [1.4, 1.6] | 1.1 [1.0, 1.2] | 1.4 [1.3, 1.5] |
HD-AVF/AVG | 0.9 [0.8, 1.0] | 0.8 [0.7, 0.9] | 0.8 [0.8,0.9] | ||
Year 3 | |||||
PD | 1.0 | PD | 1.0 | 1.0 | 1.0 |
HD | 0.8 [0.7, 0.9] | HD-CVC | 1.2 [1.1, 1.4] | 0.9 [0.8, 1.0] | 1.2 [1.2, 1.3] |
HD-AVF/AVG | 0.9 [0.8, 1.0] | 0.7 [0.6, 0.8] | 0.8 [0.7, 0.9] | ||
Year 4 | |||||
PD | 1.0 | PD | 1.0 | 1.0 | 1.0 |
HD | 0.8 [0.7,1.0] | HD-CVC | 1.3 [1.1, 1.5] | 0.9 [0.8, 1.0] | 1.2 [1.1, 1.2] |
HD-AVF/AVG | 1.1 [0.9, 1.3] | 0.8 [0.7, 1.0] | 0.8 [0.7,0.9] | ||
Year 5 | |||||
PD | 1.0 | PD | 1.0 | 1.0 | 1.0 |
HD | 0.8 [0.7, 0.9] | HD-CVC | 1.2 [1.1, 1.5] | 0.9 [0.7, 1.0] | 1.2 [1.1,1.2] |
HD-AVF/AVG | 1.1 [0.9, 1.3] | 0.8 [0.7, 1.0] | 0.8 [0.8,0.9] |
aTime-dependent hazard ratios within each year were used to assess annual mortality risk.
bIntention to treat, adjusted for age, race, gender, era of dialysis initiation, end-stage renal disease comorbidity index, primary renal diagnosis, serum albumin, estimated glomerular filtration rate, province of treatment, and late referral.
cTime-averaged hazard ratios from a proportional hazards model were used to assess the cumulative treatment effect from day 0 through the end of years 1 to 5, respectively.
dOverall model and time average models constructed using 29,647 subjects using proportional hazards model, remainder of time-dependent models using nonproportional hazards model.